Zhou et al. Journal of Experimental & Clinical Cancer Research 2011, 30:72 http://www.jeccr.com/content/30/1/72 Page 7 of 7 with early breast cancer receiving adjuvant letrozole: Z-FAST study 36- month follow-up results. Clin Breast Cancer 2009, 9:77-85. 19. Eidtmann H, de Boer R, Bundred N, Llombart-Cussac A, Davidson N, Neven P, von Minckwitz G, Miller J, Schenk N, Coleman R: Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol 2010, 21:2188-2194. 20. Reid DM: Prevention of osteoporosis after breast cancer. Maturitas 2009, 64:4-8. 21. Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S: The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol 2011, 137:1053-1060. 22. Zhou WB, Ding Q, Chen L, Liu XA, Wang S: Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials. Breast Cancer Res Treat 2011, 128:625-631. 23. Liu X, Wang Z, Yu J, Lei G, Wang S: Three polymorphisms in interleukin- 1beta gene and risk for breast cancer: a meta-analysis. Breast Cancer Res Treat 2010, 124:821-825. 24. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826. 25. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748. 26. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 27. Leal T, Tevaarwerk A, Love R, Stewart J, Binkley N, Eickhoff J, Parrot B, Mulkerin D: Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer. Clin Breast Cancer 2010, 10:471-476. 28. Swenson KK, Nissen MJ, Anderson E, Shapiro A, Schousboe J, Leach J: Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy. J Support Oncol 2009, 7:101-107. 29. Kim JE, Ahn JH, Jung KH, Kim SB, Kim HJ, Lee KS, Ro JS, Park YH, Ahn JS, Im YH, Im SA, Lee MH, Kim SY: Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01). Breast Cancer Res Treat 2011, 125:99-106. 30. Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R: Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. J Clin Oncol 2010, 28:967-975. 31. Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA: Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol 2009, 27:1047-1053. 32. Markopoulos C, Tzoracoleftherakis E, Polychronis A, Venizelos B, Dafni U, Xepapadakis G, Papadiamantis J, Zobolas V, Misitzis J, Kalogerakos K, Sarantopoulou A, Siasos N, Koukouras D, Antonopoulou Z, Lazarou S, Gogas H: Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast Cancer Res 2010, 12:R24. 33. Diel IJ, Bergner R, Grotz KA: Adverse effects of bisphosphonates: current issues. J Support Oncol 2007, 5:475-482. doi:10.1186/1756-9966-30-72 Cite this article as: Zhou et al.: Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta- analysis. Journal of Experimental & Clinical Cancer Research 2011 30:72. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit